OmniAb, Inc.
A technology platform for pharma/biotech to discover therapeutic antibodies via transgenic animals.
OABIW | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 5980 HORTON STREET, 94608 EMERYVILLE
- Website:
- https://www.omniab.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
OmniAb, Inc. is a biotechnology company that provides the pharmaceutical and biotech industries with a technology platform for therapeutic antibody discovery. The company enables partners to discover next-generation therapeutics by offering access to a diverse suite of proprietary technologies. This includes clinically proven transgenic animal models, such as transgenic chickens (OmnidAb®), capable of generating high-quality, fully human antibodies and diverse antibody repertoires. OmniAb also provides cutting-edge, high-throughput screening technologies (e.g., xPloration®) and computationally powered antigen design. It licenses its integrated platform to biopharmaceutical companies and academic research institutions to advance their clinical drug development programs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all OmniAb, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for OmniAb, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for OmniAb, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
